LTROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)-MedSci.cn

LTROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

Paz-Ares, L; Ahn, MJ; Lisberg, AE; Kitazono, S; Cho, BC; Blumenschein, G; Shum, E; Pons-Tostivint, E; Goto, Y; Yoh, K; Heist, R; Baas, P; Planchard, D; Pérol, M; Felip, E; Su, WC; Zebger-Gong, H; Lan, L; Liu, C; Sands, J

ANNALS OF ONCOLOGY, 2023; 34 ():

科室
- - 订阅+
  - 更多科室
工具
服务